Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 101 - 110 of 224 for bayer. (0.12 seconds)

Qiming Venture Partners announced a 250 million RMB...
China life science IPOs raised $5.4 billion in the last...
Shanghai Pharmaceuticals will raise 8 billion RMB ($1.2...
CCB’s $400 million China health care fund may...
“In 2010, venture capital investment in China life...
According to reports, China will invest $1.7 trillion...
China released its 12th Five-year Plan for Medical...
OriGene Technologies, a US research tool maker, acquired...
Chongqing Huapont Pharma plans to raise $146 million in a...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here